methyl salicylate has been researched along with thromboxane b2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carmo, LG; Hatmi, M; Rotilio, D; Vargaftig, BB | 1 |
Chisholm, CB; Danish, DC; Matteucci, MJ; Reardon, JM; Riffenburgh, RH; Tanen, DA | 1 |
1 trial(s) available for methyl salicylate and thromboxane b2
Article | Year |
---|---|
Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Area Under Curve; Aspirin; Cross-Over Studies; Double-Blind Method; Epinephrine; Humans; Immunoenzyme Techniques; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Salicylates; Statistics, Nonparametric; Thromboxane B2; Time Factors | 2008 |
1 other study(ies) available for methyl salicylate and thromboxane b2
Article | Year |
---|---|
Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Topics: Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; Imidazoles; Indoles; Microscopy, Electron; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Salicylates; Thrombin; Thromboxane B2 | 1985 |